Key result
Astragaloside IV significantly promoted the pharmacological efficacy of Descurainia sophia seeds in alleviating isoproterenol-induced cardiomyopathy in rats by modulating the myosin motor.
Why the study?
Descurainia sophia and Astragalus mongholicus are widely used to treat heart failure in traditional Chinese medicine, but their molecular mechanisms of action are not completely understood.
Does astragaloside IV combined with Descurainia sophia seeds improve isoproterenol-induced cardiomyopathy in rats compared to disease models or monotherapy?
Does astragaloside IV combined with Descurainia sophia seeds improve isoproterenol-induced cardiomyopathy in rats compared to disease models or monotherapy?
Astragaloside IV synergistically enhances the efficacy of Descurainia sophia seeds in treating isoproterenol-induced cardiomyopathy by modulating the myosin motor and downregulating cardiomyopathy biomarkers.
Hypothesis-generating in rat cardiomyopathy models; extends preclinical myosin modulation data but requires human trials before any clinical consideration.
(AM), and their formulas are widely used to treat heart failure caused by various cardiac diseases in traditional Chinese medicine practice. However, the molecular mechanism of action of DS and AM has not been completely understood. Herein, we first used mass spectrometry coupled to UPLC to characterize the chemical components of DS and AM decoctions, then applied MS-based quantitative proteomic analysis to profile protein expression in the heart of rats with isoproterenol-induced cardiomyopathy (ISO-iCM) before and after treated with DS alone or combined with AM, astragaloside IV (AS4), calycosin-7-glucoside (C7G), and Astragalus polysaccharides (APS) from AM. We demonstrated for the first time that DS decoction alone could reverse the most of differentially expressed proteins in the heart of the rats with ISO-iCM, including the commonly recognized biomarkers natriuretic peptides (NPPA) of cardiomyopathy and sarcomeric myosin light chain 4 (MYL4), relieving ISO-iCM in rats, but AM did not pronouncedly improve the pharmacological efficiency of DS. Significantly, we revealed that AS4 remarkably promoted the pharmacological potency of DS by complementarily reversing myosin motor MYH6/7, and further downregulating NPPA and MYL4. In contrast, APS reduced the efficiency of DS due to upregulating NPPA and MYL4. These findings not only provide novel insights to better understanding in the combination principle of traditional Chinese medicine but also highlight the power of mass spectrometric proteomics strategy combined with conventional pathological approaches for the traditional medicine research.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2022) studied Isoproterenol-induced cardiomyopathy (n=77). Descurainia sophia seeds combined with astragaloside IV vs. Model group (normal saline) was evaluated on Left ventricular ejection fraction (LVEF) and protein expression. Astragaloside IV significantly promoted the pharmacological efficacy of Descurainia sophia seeds in alleviating isoproterenol-induced cardiomyopathy in rats by modulating the myosin motor.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: